Nasdaq Gives Canary's Proposed Staked INJ ETF Green Light
The Nasdaq plan uses ticker INJC. The proposal calls for staking at least 90% of the fund’s INJ holdings under normal conditions.

Nasdaq has given Canary Capital’s proposed staked Injective (INJ) ETF a green light to trade under ticker INJC. The development advances a U.S. exchange listing plan for a fund built around INJ exposure.
The proposal seeks to reflect the value of INJ held by the trust. Staking rewards are a secondary investment objective, and the proposal calls for staking at least 90% of the fund’s INJ holdings under normal conditions. Those terms describe the proposed fund, whose Nasdaq plan uses ticker INJC.
The Nasdaq plan follows an earlier proposal for shares to trade on Cboe BZX under ticker INJS, subject to approvals. Canary later shifted the proposed listing venue and ticker, a change detailed in coverage of the proposed staked INJ ETF.